Clinical Report: Assessing the Uric Acid-to-Albumin Ratio as a Predictor of CIN

Overview

This study evaluates the uric acid-to-albumin ratio (UAR) as a predictor of contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). The incorporation of UAR into a clinical prediction model significantly enhances pre-procedural risk stratification for CIN.

Background

Contrast-induced nephropathy (CIN) is a common and serious complication following percutaneous coronary intervention (PCI), leading to increased morbidity and mortality. Accurate pre-procedural risk assessment is crucial for identifying patients at high risk for CIN, allowing for targeted preventive strategies. The study investigates the potential of UAR as a novel biomarker to improve risk stratification in this patient population.

Data Highlights

Key Findings

• CIN occurred in 9.6% of the studied cohort.
• The UAR was identified as the strongest single predictor of CIN.
• Incorporating UAR into the base model significantly increased the AUC from 0.850 to 0.921.
• The UAR-augmented model demonstrated a categorical NRI of 0.296 and an IDI of 0.120.
• A nomogram incorporating UAR was developed, showing improved calibration and clinical decision-making benefits.

Clinical Implications

The UAR can serve as a valuable tool for clinicians to enhance pre-procedural risk assessment for CIN in patients undergoing PCI. By integrating UAR into clinical practice, healthcare providers may improve patient outcomes through better identification of high-risk individuals and tailored preventive strategies.

Conclusion

The uric acid-to-albumin ratio is a promising predictor of contrast-induced nephropathy following PCI. Further validation is needed to confirm its utility in clinical settings before widespread adoption.

Related Resources & Content

1. European Journal of Preventive Cardiology, 2023 -- Revisiting the Urine Albumin-Creatinine Ratio: A Timeless Indicator in Modern Cardiovascular Risk Assessment
2. The Journal of Clinical Endocrinology & Metabolism, 2023 -- A New Predictive Model for Kidney Failure in Chronic Kidney Disease Patients: The Role of Serum Bilirubin Concentrations
3. Frontiers in Medicine, 2023 -- LDAR Outperforms Other Albumin-Derived Indices in Predicting 28-Day ICU Mortality in Critically Ill Myocardial Infarction Patients: A Two-Cohort Study
4. European Radiology — Correction: Key Factors in Assessing Acute Kidney Injury Risk: Absolute and Relative GFR alongside Contrast Medium Dose/GFR Ratio
5. ACR Manual on Contrast Media
6. SCAI Quality Initiatives
7. NCDR Studies Present Updated AKI Risk Model